image
Innate Pharma S.A. IPHA
Healthcare - Biotechnology - NASDAQ - FR
Watchlist
$ 1.44
-11.7 %
$ 117 M
Market Cap
-3.27
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 4.56% 92.36% -8.74%
Annual Report FY 10-K 2022-12-31 309.83% -67.58% 75.64%
Annual Report FY 10-K 2021-12-31 -78.69% 16.41% -249.29%
Annual Report FY 10-K 2020-12-31 -17.60% -237.45% 49.39%
Annual Report FY 10-K 2019-12-31 -13.67% -687.60% -525.71%
Annual Report FY 10-K 2018-12-31 144.83% 106.30% 112.87%
Annual Report FY 10-K 2017-12-31 -41.90% -382.79% -528.11%
Annual Report FY 10-K 2016-12-31 213.64% 288.49% 170.28%
Annual Report FY 10-K 2015-12-31 1874.20% 65.87% 46.05%
Annual Report FY 10-K 2014-12-31 -92.73% -579.36% -614.86%
Annual Report FY 10-K 2013-12-31 20.16% 9.60% 17.51%
Annual Report FY 10-K 2012-12-31 -11.61% 54.17% 55.27%
Annual Report FY 10-K 2011-12-31 171.76% 48.89% 44.70%
Annual Report FY 10-K 2010-12-31 -44.01% 6.62% 11.88%
Annual Report FY 10-K 2009-12-31 -40.30% -48.46% -41.15%
Annual Report FY 10-K 2008-12-31 -9.56% -10.47% -21.06%
Annual Report FY 10-K 2007-12-31 130.67% -47.60% -25.58%
Annual Report FY 10-K 2006-12-31 376.54% 1.42% -12.84%
Annual Report FY 10-K 2005-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-06-30 -82.54% -720.72% -150.46%
Quarterly Report Q1 8-K 2024-03-31 -69.29% -1441.44% -6494.74%
Quarterly Report Q4 8-K 2023-12-31 29.03% 92.79% 78.70%
Quarterly Report Q3 8-K 2023-09-30 77.43% 85.57% 50.76%
Quarterly Report Q2 8-K 2023-06-30 -14.36% -72.74% -125.82%
Quarterly Report Q1 8-K 2023-03-31 -11.83% -73.06% -4.70%
Quarterly Report Q4 8-K 2022-12-31 197.49% -121.40% 6.79%
Quarterly Report Q3 8-K 2022-09-30 6.09% -129.75% 8.68%
Quarterly Report Q2 8-K 2022-06-30 342.87% 126.57% 115.71%
Quarterly Report Q1 8-K 2022-03-31 242.47% 136.50% 141.35%
Quarterly Report Q4 8-K 2021-12-31 -89.65% 45.78% -77.47%
Quarterly Report Q3 8-K 2021-09-30 -66.20% 47.79% -167.54%
Quarterly Report Q2 8-K 2021-06-30 -68.77% -129.52% -64.60%
Quarterly Report Q1 8-K 2021-03-31 -63.77% -69.05% -146.03%
Quarterly Report Q4 8-K 2020-12-31 55.25% -57.80% 58.00%
Quarterly Report Q3 8-K 2020-09-30 26.43% -57.80% 72.06%
Quarterly Report Q2 8-K 2020-06-30 -42.16% -78.05% -282.85%
Quarterly Report Q1 8-K 2020-03-31 -37.88% -78.05% -88.28%
Quarterly Report Q4 8-K 2019-12-31 -50.99% -374.29% -413.56%
Quarterly Report Q3 8-K 2019-09-30 -62.43% -187.15% -182.10%
Quarterly Report Q2 8-K 2019-06-30 348.67% 275.16% 176.62%
Quarterly Report Q1 8-K 2019-03-31 157.24% 187.58% 163.45%
Quarterly Report Q4 8-K 2018-12-31 211.77% 172.59% 192.17%
Quarterly Report Q3 8-K 2018-09-30 211.77% 172.59% 192.17%
Quarterly Report Q2 8-K 2018-06-30 8.09% 35.28% 18.26%
Quarterly Report Q1 8-K 2018-03-31 8.09% 35.28% 18.26%
Quarterly Report Q4 8-K 2017-12-31 -49.46% -158.28% -207.19%
Quarterly Report Q3 8-K 2017-09-30 -49.46% -158.28% -207.19%
Quarterly Report Q2 8-K 2017-06-30 2.85% -636.64% -522.86%
Quarterly Report Q1 8-K 2017-03-31 2.85% -636.64% -522.86%
Quarterly Report Q4 8-K 2016-12-31 119.68% 1097.80% 15114.49%
Quarterly Report Q3 8-K 2016-09-30 119.68% 1097.80% 15114.49%
Quarterly Report Q2 8-K 2016-06-30 345.80% 60.49% 73.00%
Quarterly Report Q1 8-K 2016-03-31 345.80% 60.49% 73.00%
Quarterly Report Q4 8-K 2015-12-31 488.10% 112.44% 100.63%
Quarterly Report Q3 8-K 2015-09-30 488.10% 112.44% 100.63%
Quarterly Report Q2 8-K 2015-06-30 12.16% 11.21% -19.64%
Quarterly Report Q1 8-K 2015-03-31 12.16% 11.21% -19.64%
Quarterly Report Q4 8-K 2014-12-31 -63.96% -1764.32% -1675.90%
Quarterly Report Q3 8-K 2014-09-30 -63.96% -1764.32% -1675.90%
Quarterly Report Q2 8-K 2014-06-30 -40.71% -289.11% -316.45%
Quarterly Report Q1 8-K 2014-03-31 -40.71% -289.11% -316.45%
Quarterly Report Q4 8-K 2013-12-31 47.39% 51.70% 48.05%
Quarterly Report Q3 8-K 2013-09-30 47.39% 51.70% 48.05%
Quarterly Report Q2 8-K 2013-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2013-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2012-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2012-09-30 0.00% 0.00% 0.00%